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In the unprecedented current era of the COVID-19 pandemic, challenges have arisen in
the management and interventional care of patients with acute stroke and large vessel
occlusion, aneurysmal subarachnoid hemorrhage, and ruptured vascular malformations.
There are several challenges facing endovascular therapy for stroke, including shortages
of medical staff who may be deployed for COVID-19 coverage or who may have
contracted the infection and are thus quarantined, patients avoiding early medical
care, a lack of personal protective equipment, delays in door-to-puncture time,
anesthesia challenges, and a lack of high-intensity intensive care unit and stroke ward
beds. As a leading regional neurovascular organization, the Middle East North Africa
Stroke and Interventional Neurotherapies Organization (MENA-SINO) has established
a task force composed of medical staff and physicians from different disciplines to
establish guiding recommendations for the implementation of acute care pathways
for various neurovascular emergencies during the current COVID-19 pandemic. This
consensus recommendation was achieved through a series of meetings to finalize
the recommendation.
Keywords: COVID, endovascular therapy, recommendation, MENA, acute ischemic stroke, subarachnoid
hemorrhage
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BACKGROUND
The novel coronavirus disease (COVID-19) was first identified
in the Wuhan province of China in late December 2019 and
spread rapidly around the globe. Consequently, a pandemic
characterized by a rapid spread through respiratory droplets with
human-to-human contact was declared by the World Health
Organization on March 11, 2020 (1–4).
COVID-19 in the Middle East
COVID-19 is the second coronavirus outbreak to affect the
Middle East, following the MERS-CoV reported in Saudi Arabia
in 2012. The United Arab Emirates (UAE) was the first Middle
East country to report a coronavirus-positive case, following the
Wuhan coronavirus outbreak in China (4).
COVID-19 and Stroke
COVID-19 is increasingly being recognized as a cause of
thromboembolic phenomena, such as acute ischemic strokes and




Patient Avoidance of Seeking Medical
Attention
Published and anecdotal reports suggest that during the
pandemic, there has been a drastic reduction in the number of
stroke patients being evaluated in the emergency room (ER) or
being admitted to hospitals worldwide (6). It is highly unlikely
that the incidence of stroke has suddenly changed or reduced.
This could be explained by the inability to seek medical care due
to the extreme restrictions established to limit virus transmission
or fear of contracting the virus upon visiting the hospital.
In addition tertiary care hospitals may be inundated with
COVID-19 patients, and as such, patients with stroke are being
treated at secondary-care facilities or may not be transferred to
comprehensive stroke centers at all. Clearly, strokes remain an
emergency, and patients should seek immediate care despite the
current pandemic.
Healthcare Personnel Shortages
Healthcare personnel have a high risk of becoming infected
during this novel pandemic, particularly before transmission
dynamics are fully characterized. Of the COVID-19 cases
reported to the Centers for Disease Control from February 12
to April 9, a proportion included data on whether the patient
was a healthcare worker (HCW) in the USA, with up to 19%
of cases identified as healthcare personnel (7). Quarantines for
HCWs who have tested positive and for those with high-risk
exposures could severely impact the smooth functioning of stroke
units and may even jeopardize an entire department if it involves
small numbers (e.g., a neurointerventional team). In addition,
many hospitals are redeploying clinicians of all specialties to the
care of COVID-19 patients, thereby draining resources of care
for other medical conditions. Both of the above factors present
a substantial challenge, even for well-established stroke centers,
and stroke teams will likely experience staff shortages.
Hospital Beds for Stroke
It is likely that hospitals will be inundated with COVID-19
patients. Specifically, these patients will include individuals who
are critically ill from a respiratory viewpoint; these patients will
require intensive care unit (ICU) hospitalization, and many will
require ventilators. Thus, disruptions in standard protocols such
as post-thrombolysis and post-thrombectomy care should be
expected, and variations in protocol or abbreviated protocols
will be needed to efficiently utilize staffing and bed space while
maintaining the best possible patient care. Repatriation from a
comprehensive stroke center to lower levels of care following a
period of stability after critical procedures, such as mechanical
thrombectomy, aneurysm occlusion, or hematoma evacuation,
may be reasonable (8).
Shortage of Personal Protective Equipment
The provision of adequate personal protective equipment (PPE)
and clear guidelines on its application are imperative to protect
healthcare personnel and to prevent viral spread among HCWs.
Given that community transmission of COVID-19 is well-
established in most areas, all stroke alerts presenting to the
ER should ideally be treated as a potentially infected patient.
While the use of PPE for maximum protection, as dictated
by international and institutional bodies, is ideal, this practice
may not be possible given the PPE shortages that are being
encountered in many countries (9). Thus, responses to code
stroke may be delayed due to PPE unavailability.
Anesthesia Challenges
Known or suspected COVID-19 patients as well as carriers
will likely require mechanical thrombectomy for large vessel
occlusion. This situation poses challenges regarding anesthetic
management, given the urgent nature of the procedure and
an “unknown” COVID-19 status. COVID-19 has a high risk
of spreading through droplets and aerosols (1, 10). Bag-mask
ventilation, intubation, extubation, and airway suctioning are
aerosol-generating procedures, and any disconnection of the
circuit risks further aerosolizing secretions. In theory, monitored
anesthesia care (MAC) may prevent intense aerosolization;
however, stroke patients undergoing MAC sedation may require
supplemental oxygen via a nasal cannula mask or other
methods, such as chin-lift or jaw thrust maneuvers, to improve
oxygenation, whichmay increase the degree of airborne exposure
to the anesthesia provider and other involved HCWs. Another
consideration is the need to convert from MAC to general
anesthesia (GA) in a minority of patients. Urgent intubation
in a non-negative pressure room introduces an exposure
risk to all team members within the room. In addition,
workflows with regard to dedicated space for intubation pose
additional challenges.
Delay in Treatment Timelines
While prehospital delays are expected, given travel, and transfer
logistics amidst ongoing community lock-downs in many
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countries, several challenges remain once the patient arrives
at the ER. Protocols for protected stroke alerts have been
published. Limited neurology personnel, PPE shortages, transfer
times through designated corridors/elevators from the ER to
imaging with appropriate PPE, unavailability of computerized
tomography (CT) scanners during disinfection periods, and
time for donning/doffing PPE are all potential factors that
may increase door-to-needle times when treating patients
with intravenous thrombolysis as well as door-to-puncture
for thrombectomy.
Angiography Suite
To minimize exposure, staffing within the room should
be kept to a minimum; however, some patients may be
technically challenging, and an additional handmay be extremely
helpful. Challenges while operating with multiple layers of
PPE are foreseeable. The physical and psychological burden
of neurointerventional stroke calls, particularly during the
current pandemic, is likely substantial, especially given the
small size of these teams. As reported by a recent survey of
neurointerventional nurses and radiology technologists from 20
stroke centers in the USA, only 9 centers (45%) had more
than 6 nurses or technologists in their call pools for stroke
(11). Many institutions with multiple angiography suites are




As a leading regional neurovascular organization, MENA-
SINO has established a task force comprised of physicians,
nurses, and medical staff from different disciplines (neurology,
neurosurgery, interventional neuroradiology, and neurocritical
care) to establish guiding recommendations for the
implementation of acute care pathways for various neurovascular
emergencies during the current COVID-19 pandemic. These
recommendations can be greatly enhanced by telemedicine
options to minimize patient–physician interactions, as dictated
by clinical needs. Other international entities have also published
different guidelines, all aiming at achieving “protected code
stroke protocol” (12–14).
We describe the following guiding recommendations to be
implemented in the MENA region to facilitate care for patients
and to provide optimal protection for HCWs.
1. Patients must be properly triaged to guide the safety of their
clinical encounter (Figure 1).
2. A clear standardized list of priorities for treatment must
be established across the different neurovascular pathologies
(Table 1). This standardization will render treatments more
efficient and will allow for optimal healthcare delivery, by
establishing proper operational policies.
3. Outpatient and office visits should be conducted virtually to
avoid unnecessary contact between patients and physicians.
4. Each patient should be transferred to another institution if
required, as soon as he/she is sufficiently stable to receive the
required intervention (Table 1).
5. COVID and non-COVID regions should be designated within
the hospital to guide the safety and reciprocity of patient
transfers between institutions.
The following process is recommended for the
referring hospital:
Prehospital Stage
For all stroke patients presenting directly to the ER or being
transferred, the following measures should be taken.
1. Infection control screening: Symptoms or signs of COVID-19,
history of infection, contact with infected persons, and travel
history should be obtained by emergency medical services
(EMS) personnel evaluating the patient at the first encounter.
2. All patients should wear a surgical mask when able,
irrespective of the screening outcome.
3. Pre-notification: Hospitals should be pre-notified regarding
stroke specifics, COVID screening results, and suspicious
cases, if any.
4. When available, telemedicine should be utilized for triage in
the prehospital phase. If telemedicine is not available, off-
label use of social messaging applications for remote medical
consultation can be used, although caution is needed to
respect patient data confidentiality.
Hospital Stage
Emergency Room
1. The ER should be divided such that separate spaces and
corridors are available for COVID and non-COVID patients.
2. To screen for symptoms of COVID-19 in expeditedmanner to
conform to the time-critical nature of stroke care (Figure 1).
3. All patients should wear a surgical mask.
4. Patients with a positive infection screen or those highly
suspected, as reported by emergency medical services (EMS)
or ER personnel should be roomed in a dedicated COVID area
or negative-pressure room if available.
5. Telemedicine (telestroke) should be utilized when available
to obtain history and to perform a neurological examination
in order to limit direct contact between medical staff
and patients.
6. A protective code stroke protocol should be established for
patients with a positive COVID screen. One member of
the stroke team should perform the evaluation and provide
therapy donning full PPEs.
7. A scoring system should be established for risk
stratification of HCW exposure and risk of COIVD-19
infection (Table 2).
Acute Imaging
1. Standard hospital imaging protocols should be followed for
acute stroke treatments.
2. If multiple CT rooms are available, a dedicated CT scan room
for COVID-19 patients should be established, provided that
the addition of the chest CT does not incur a treatment delay
of more than 5min.
3. If positive pulmonary symptoms are present, consider
performing low-dose chest CT simultaneously with head CT
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FIGURE 1 | Triage algorithm for EVT patients.
TABLE 1 | EVT priority of transfer based on disease entity.
Category Timeline Disease entity
Priority 1 Immediate: Acute life- threatening condition or acute transfer
within 6 h
Acute ischemic stroke (AIS)
Priority 2 Within 24 h: Loss of life or significant function that can be
saved Coiling or clipping of a ruptured saccular aneurysm with SAH
Craniotomy or embolization of a ruptured AVM with prenidal/nidal
aneurysms
Decompressive craniectomy or hematoma evacuation*
1. If there is not a high risk for in-hospital mortality (inferred from mortality and prognosis assessment scales such as SOFA)
Priority 3 Within 1 week: Life or significant functional loss that can be
saved by intervention within 1 week
Complex ruptured intracranial aneurysm requiring special preparation
or equipment
Priority 4 Within 1 month: Life or significant functional loss that can be
saved by intervention within 1 month
1. Ruptured AVM with no nidal aneurysms
2. High-grade dural AV fistulae with ICH
3. Carotid revascularization (endarterectomy or stenting) for
symptomatic carotid stenosis
Priority 5 After the COVID-19 pandemic Any other pathology with non-hemorrhagic or ischemic presentation,
with a strong recommendation to address risk factors and provide
continuous surveillance
using head and neck CT angiography (CTA). It is also wise
to include chest CT in the stroke protocol, as PCR tests
and the absence of pulmonary symptoms do not exclude the
possibility of COVID-19 infection.
4. Avoid multiple visits to the CT room to minimize exposure.
5. For acute imaging, magnetic resonance imaging (MRI) should
be avoided if possible. The use of MRI should be restricted to
absolute necessities, following the guidance provided by the
American College of Radiology on the use of MRI (15).
Acute Stroke Treatment: Intravenous
Thrombolysis and Endovascular
Thrombectomy
1. Patients should continue to be treated according to current
standard guidelines for intravenous thrombolysis and
endovascular mechanical thrombectomy, with the best
adherence possible (16).
2. Although there are some situations for which the current
guidelines have no clear answers or strong recommendations,
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TABLE 2 | Healthcare worker exposure risk stratification.
Risk attribute for contact with
COVID-19 patient
Score 1 Contact duration Score 2 Distance Score 3 Total score Risk stratification
Health worker wearing proper protective
gear
0 Less than 20min 1 More than 1.5m (6 feet) 1 _________ Score 2–3: Low risk
More than 20min 2 Less than 1.5m (6 feet) 2
Health worker NOT wearing proper
protective gear
1 Less than 20min 1 More than 1.5m (6 feet) 1 Score 4–5: High risk
More than 20min 2 Less than 1.5m (6 feet) 2
Adopted from the MOH, Saudi Arabia.
the decision to treat a patient should take into account
the seriousness of the COVID-19 disease and prognosis,
particularly with regard to endovascular thrombectomy.
For patients with evidence of multi-organ dysfunction or
critical illness, outcomes of endovascular intervention may
be suboptimal, and the risks and benefits of such procedures
must be weighed against the consumption of resources
and potential exposure to caregivers. A multidisciplinary
discussion among the treating physicians should be held to
make the most appropriate treatment decision.
Airway Management
1. The anesthesia team should be notified as soon as possible
regarding potential endovascular procedures.
2. Conscious sedation should be considered as first-line
treatment for patients with acute stroke interventions, if
the patient is stable. However, a low threshold should be
maintained for intubation in patients with respiratory distress,
inability to protect the airway, posterior circulation stroke,
vomiting, or agitation and for those who are uncooperative.
3. Intubation should be performed in a negative-pressure room
separate from the angiography suite or in a dedicated
angiography suite with negative pressure capabilities. In the
absence of negative pressure, an aerosol box can be a good
substitute in special situations (17).
4. Extubation should be avoided in the angiography suite and
instead be performed in a negative-pressure room.
5. Transfers should avoid breaking the initial ventilator circuit,
bagging, or reconnection to a new ventilator.
The following process is recommended for the
referring hospital:
1. Acute ischemic stroke
a) All patients must be screened for COVID-19. The use of
telecommunication is recommended if available.
b) Any patient with fever or respiratory symptoms should
be disclosed upon the referral request to ensure proper
precautions [as a COVID-19-positive individual or person
under investigation [PUI]] and to ensure that trends of vital
signs are properly recorded.
c) The National institute of health stroke scale (NIHSS) must
be documented, and the score must exceed 5 for a transfer
to be considered.
d) Perform brain non-contrast CT (NCCT) to rule out
hemorrhage or the presence of an established infarction
(Alberta stroke program early CT score (ASPECTS)
above 6).
e) Perform CTA to confirm the occurrence of large
vessel occlusion and CT perfusion to identify a
mismatch. A higher large vessel occlusion (LVO) score
may be acceptable for transfer, depending on local
logistic preparedness.
f) Patients with a high risk of COVID-19 should wear a
surgical mask.
g) Obtain chest CT at the time of the initial CT (ground-
glass appearance).
h) If the patient presents with an unknown time of onset or
a delayed onset, the option of obtaining a CT perfusion or
a brain MRI should be offered in the receiving hospital to
assess any mismatch prior to a consideration of transfer. If
this procedure is not feasible, the ASPECTS should guide
the transfer, with tissue imaging performed in the receiving
stroke center.
∗∗ Intravenous tissue plasminogen activator (IV-tPA) eligible
patients should receive thrombolysis based on the protocol
in the referring hospital (telestroke managed or guided by
stroke neurology).
2. Aneurysmal subarachnoid hemorrhage (aSAH)
a) All patients must be screened for COVID-19, as
described above.
b) Any patient with fever or respiratory symptoms should
be disclosed upon the referral request to ensure proper
precautions (as a COVID-19-positive individual or
PUI) and to ensure that the trends of vital signs are
properly recorded.
c) Glasgow coma scale (GCS) and World federation
of neurosurgical societies (WFNS) grades must be
documented (consideration for transfer: GCS > 9 and
WFNS grade 1–3).
d) Perform brain NCCT to document the SAH and to exclude
intraventricular hemorrhage or intracerebral hemorrhage
(IVH-ICH) and hydrocephalus requiring an external
ventricular drain (EVD).
e) Perform CTA to confirm the presence of
intracranial aneurysm and to rule out any other
vascular pathology.
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f) Obtain chest CT at the time of the initial CT (ground-glass
appearance) for the above-mentioned reasons.
g) If the CTA is negative for aneurysm, the transfer should
be aborted, and repeat vascular imaging (CTA or digital
subtraction angiography [DSA]) should obtained within
7 days.
∗∗ In the case of a high-grade SAH, improvement after the
EVD insertion should warrant a referral request.
3. After the need for an interventional procedure has been
confirmed, the following steps should be taken:
a) The patient should be intubated in the referring hospital,
and a closed circuit should be ensured throughout the
process of transferring from and to the referring hospital.
b) The patient must be accompanied by a medical transfer
team that follows strict PPE precautions. This team should
be equipped to offer hemodynamic and ventilatory support
during the transfer.
c) The patient should be connected to a portable ventilator
that will be used throughout the transfer process, including
the angiographic procedure, to ensure that the closed
ventilatory circuit is not interrupted.
Precautions during the endovascular procedure
All patients should be treated as though there is a high
suspicion of the patient being COVID-19-positive. Accordingly,
the following precautions should be implemented:
1. PPE for all staff coming in contact with the patient
• Lead apron and a yellow gown
• Head cover
• N-95 mask covered by a regular mask
• Goggles
• Face shield
• Sterile gown and gloves
2. Strict and supervised movement between different zones in
the angiography suite
• Cold zone outside the angiography suite (green zone:
control room)
• Intermediate zone (yellow zone: scrubbing area)
• Hot zone (red zone: inside the angiography suite)
3. The angiogram set, pressure bags, and basic access catheters
should be prepared for use before the patient enters the
angiogram suite. Ready-to-use verapamil and heparin syringes
should be included in the angiogram set, and a vial of
actylase (IV tPA) should be available in the cold zone. Other
antiplatelet agents can be added based on local protocols.
4. A high-efficiency particulate air (HEPA) filter should be placed
by the door of the angiogram suite.
5. All closets and cabinets should be closed during the
angiography procedure.
6. The room should be labeled as COVID-19-POSITIVE, with
no entry other than the angiography team.
7. Intervention technicians should remain in the cold zone to
limit exposure and to facilitate material handling.
8. The circulating nurse should remain in the cold zone,
supervising the movement of personnel and the
donning/doffing of PPE upon entry and exit of any
angiography team member.
9. The angiography team in the hot zone should consist of
• One scrub nurse
• Up to two interventionists
• One anesthesia physician, with strict control on the airway
to avoid suctioning and aerosol leaks
10. All interventional material should remain outside the
angiography suite (in the cold zone) and should be handed to
the scrub nurse upon request.
11. The arterial access sheath should be removed at the end of
the angiographic procedure. Manual compression or a closure
device should be utilized for hemostasis.
∗∗ Depending on the policy implemented, the patient can either
remain in the treating hospital or be transferred back to their
referring hospital.
F. Teamwork during the pandemic
F.1. In any given region, neurovascular centers are advised to
reduce the number of healthcare staff on clinical duty during
the pandemic. We emphasize that all HCWs should continue
to take universal precautions and utilize PPE as guided by
the Ministries of Health and/or local institutional infection
control protocols.
F.2. Cross-privileging of neurointerventionalists during the
pandemic should be implemented if the need arises. This
approach will allow for continuous care of patients needing
these interventions.
Psychological Support for Healthcare
Workers
A recent study assessing the magnitude of mental health
outcomes and associated factors among HCWs treating patients
exposed to COVID-19 in China reported symptoms of
depression (634; 50.4%), anxiety (560; 44.6%), insomnia (427;
34.0%), and distress (899; 71.5%) (18).
Healthcare providersmay benefit from following themeasures
listed below.
◮ Self-monitor and pace.
◮ Regularly check in with colleagues, family, and friends (check-
ins may need to be virtual).
◮ Take brief relaxation/stress management breaks.
◮ Establish a COVID-free discussion zone.
◮ Seek reliable information and proper expert assessments to
assist in making informed decisions if needed.
◮ Focus efforts on what is within your power.
◮ Check in with other colleagues to discuss work experiences.
◮ Provide consultations and collegial support (remotely).
◮ Allow for “hot debriefs,” e.g., following the STOP-5 approach
(Summarize, Things that went well, Opportunities to improve,
Point to action and responsibility) adapted from the
Edinburgh emergency medicine model developed by (19).
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◮ Schedule time off from work for gradual reintegration into
personal life.
◮ Prepare for worldview changes in one’s life that may not be
mirrored by others.
CLOSING REMARKS
Despite the current challenges encountered in the EVT
treatment of acute stroke and neurointervention, there remain
opportunities to learn from the current pandemic experience,
with applications for future disasters.
In summary, our main recommendations are the following:
1- The risk of COVID-19 (Figure 1) should be stratified in order
to prioritize and optimize (Table 1) the utilization of available
resources during the COVID-19 pandemic in the MENA
region, where resources are limited.
2- The role of telestroke in acute and clinical settings is critical for
avoiding unnecessary contact between patients and physicians
during the pandemic and to better utilize specialized stroke
physicians with limited resources.
3- In an acute ischemic stroke, stringent prescreening criteria
should be implemented to distinguish high-risk COVID-
19 patients from low-risk patients, with subsequent stroke
protocols based on the COVID-19 risk.
4- In aSAH patients, prescreening should be performed
before admission and intervention, and a stringent
high-risk protocol should be followed in the
Neuro-ICU and during intervention based on
prescreening results.
In conclusion, the MENA-SINO statement provides
guidance to interventionalists and hospitals for prioritizing
medical care for neurovascular patients. While these
guidelines consider patient safety and infection protective
protocols, they do not replace sound clinical judgment, the
consideration of patient-specific factors, or institutional policies
and procedures.
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